Agreement signed with renowned research universities
19 November 2018 ASX Code: MXC
?
? ?
?
?
?
?
MGC Pharmaceuticals Ltd (ASX: MXC or “the Company”) is pleased to announce it has signed a binding partnership agreement with the Royal Melbourne Institute of Technology and The Hebrew University of Jerusalem to form a joint international medical research hub for medicinal cannabis innovation and technologies.
As an extension to MXC existing collaboration with RMIT, the new research hub, to be known as ‘CannaHub’, is a collaborative centre between MXC, RMIT and HUJ and will be an international shared library of research, data and analytics on medicinal cannabis and its uses including future medical applications and treatments.
to launch CannaHub
An international research hub formed for the development of world leading medicinal
cannabis research, technologies and innovations
Highlights
MXC has signed a partnership agreement with the Royal Melbourne Institute of Technology (RMIT) and The Hebrew University of Jerusalem (HUJ) to create and launch ‘CannaHub’, an international research hub for medicinal cannabis and its
future applications in the field of medicine and patient treatment
CannaHub is a new addition to the MXC projects currently underway with RMIT,
and will be formally launched in Q1 2019
CannaHub’s research projects will initially focus on the use of medicinal cannabis in the treatment of cancer, the effectiveness of traditional and medicinal cannabis
combination treatments and drug delivery systems
Partnering with world renowned Hebrew University of Jerusalem in a research
collaboration project further strengthens the Company’s business strategy to
become a leading bio-pharma, and product development company
Represents a key milestone for the Company as CannaHub will act as MXC’s primary research and new product development engine, supporting its seed-to- pharma business model through the innovation and development of new
medicinal cannabis products and technologies
All findings, outcomes and conclusions remain the property of CannaHub partners
MXC, RMIT and HUJ
MXC holds the first right to use or acquire all data, technology, or findings
generated from CannaHub with potential commercial applications
AI
